(Q46541622)

English

Osteoporosis medication dispensing for older Australian women from 2002 to 2010: influences of publications, guidelines, marketing activities and policy.

scientific article published on 30 August 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25174626%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Osteoporosis medication dispensing for older Australian women from 2002 to 2010: influences of publications, guidelines, marketing activities and policy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25174626%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

0 references

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25174626%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25174626%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

5

object named as

Annette J Dobson

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25174626%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

2

object named as

Susan E Tett

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25174626%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

4

object named as

Gita D Mishra

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25174626%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

30 August 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25174626%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Pharmacoepidemiology and Drug Safety

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25174626%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25174626%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25174626%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1303-1311

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25174626%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Understanding physician antibiotic prescribing behaviour: a systematic review of qualitative studies

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3703

21 January 2018

Factors associated with physicians' reliance on pharmaceutical sales representatives.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3703

21 January 2018

Detecting anxiety and depression in general medical settings

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3703

21 January 2018

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3703

21 January 2018

A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3703

21 January 2018

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3703

21 January 2018

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3703

21 January 2018

Osteonecrosis of the jaw and bisphosphonates

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3703

21 January 2018

Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3703

21 January 2018

Upper gastrointestinal tract safety of risedronate: a pooled analysis of 9 clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3703

21 January 2018

Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3703

21 January 2018

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3703

21 January 2018

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3703

21 January 2018

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3703

21 January 2018

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3703

21 January 2018

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3703

21 January 2018

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3703

21 January 2018

Zoledronic acid and clinical fractures and mortality after hip fracture

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3703

21 January 2018

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3703

21 January 2018

Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

1 reference

https://api.crossref.org/works/10.1002%2FPDS.3703

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46541622&oldid=1753074544"